共有 1 页
| 品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
|---|---|---|---|---|---|---|---|
| 罗恩 | R021734-1mg | 1mg | 5~7个工作日 |
VcMMAE VcMMAE |
98% |
|
|
| 罗恩 | R021734-5mg | 5mg | 5~7个工作日 |
VcMMAE VcMMAE |
98% |
|
|
| 阿拉丁 | V125591-1mg | 1mg | 现货 |
VcMMAE,用于偶联抗体 VcMMAE |
≥98% |
|
|
| 阿拉丁 | V125591-5mg | 5mg | 现货 |
VcMMAE,用于偶联抗体 VcMMAE |
≥98% |
|
|
| 阿拉丁 | V125591-10mg | 10mg | 现货 |
VcMMAE,用于偶联抗体 VcMMAE |
≥98% |
|
|
| 阿拉丁 | V125591-25mg | 25mg | 现货 |
VcMMAE,用于偶联抗体 VcMMAE |
≥98% |
|
|
| 阿拉丁 | V125591-50mg | 50mg | 现货 |
VcMMAE,用于偶联抗体 VcMMAE |
≥98% |
|
|
| 阿拉丁 | V1372357-GMP-10mg | 10mg | 期货,请咨询 |
VcMMAE VcMMAE |
|
|
|
| 阿拉丁 | V1372357-GMP-50mg | 50mg | 期货,请咨询 |
VcMMAE VcMMAE |
|
|
|
| 凯为 | JZ0036SL-100mg | 100mg | 现货 |
马来酰亚胺己酰基-缬氨酸-瓜氨酸-对氨基苄氧羰基单甲基耳... Maleimidocaproyl-valine-citr... |
98% |
|
|
| 凯为 | JZ0036SL-250mg | 250mg | 现货 |
马来酰亚胺己酰基-缬氨酸-瓜氨酸-对氨基苄氧羰基单甲基耳... Maleimidocaproyl-valine-citr... |
98% |
|
|
| 凯为 | JZ0036SL-500mg | 500mg | 现货 |
马来酰亚胺己酰基-缬氨酸-瓜氨酸-对氨基苄氧羰基单甲基耳... Maleimidocaproyl-valine-citr... |
98% |
|
|
| 凯为 | JZ0036SL-1g | 1g | 现货 |
马来酰亚胺己酰基-缬氨酸-瓜氨酸-对氨基苄氧羰基单甲基耳... Maleimidocaproyl-valine-citr... |
98% |
|
|
| 凯为 | JZ0036SL-5mg | 5mg | 现货 |
马来酰亚胺己酰基-缬氨酸-瓜氨酸-对氨基苄氧羰基单甲基耳... Maleimidocaproyl-valine-citr... |
98% |
|
|
| 凯为 | JZ0036SL-10mg | 10mg | 现货 |
马来酰亚胺己酰基-缬氨酸-瓜氨酸-对氨基苄氧羰基单甲基耳... Maleimidocaproyl-valine-citr... |
98% |
|
|
| 凯为 | JZ0036SL-25mg | 25mg | 现货 |
马来酰亚胺己酰基-缬氨酸-瓜氨酸-对氨基苄氧羰基单甲基耳... Maleimidocaproyl-valine-citr... |
98% |
|
|
| 乐研 | 1039030-100mg | 100mg | 现货 |
VcMMAE VcMMAE |
98% |
|
|
| 乐研 | 1039030-250mg | 250mg | 现货 |
VcMMAE VcMMAE |
98% |
|
|
| 乐研 | 1039030-1g | 1g | 现货 |
VcMMAE VcMMAE |
98% |
|
|
| 乐研 | 1039030-5g | 5g | 现货 |
VcMMAE VcMMAE |
98% |
|
|
| 乐研 | 1039030-10mg | 10mg | 现货 |
VcMMAE VcMMAE |
98% |
|
|
| 乐研 | 1039030-50mg | 50mg | 现货 |
VcMMAE VcMMAE |
98% |
|
|
| 乐研 | 1039030-5mg | 5mg | 现货 |
VcMMAE VcMMAE |
98% |
|
|
| 毕得 | BD317613-10mg | 10mg | 现货 |
4-((S)-2-((S)-2-(6-(2,5-二氧代-... 4-((S)-2-((S)-2-(6-(2,5-Diox... |
98% |
|
|
| 毕得 | BD317613-50mg | 50mg | 现货 |
4-((S)-2-((S)-2-(6-(2,5-二氧代-... 4-((S)-2-((S)-2-(6-(2,5-Diox... |
98% |
|
|
| 毕得 | BD317613-25mg | 25mg | 现货 |
4-((S)-2-((S)-2-(6-(2,5-二氧代-... 4-((S)-2-((S)-2-(6-(2,5-Diox... |
98% |
|
|
| 毕得 | BD317613-100mg | 100mg | 现货 |
4-((S)-2-((S)-2-(6-(2,5-二氧代-... 4-((S)-2-((S)-2-(6-(2,5-Diox... |
98% |
|
|
| 毕得 | BD317613-1g | 1g | 现货 |
4-((S)-2-((S)-2-(6-(2,5-二氧代-... 4-((S)-2-((S)-2-(6-(2,5-Diox... |
98% |
|
|
| 毕得 | BD317613-250mg | 250mg | 现货 |
4-((S)-2-((S)-2-(6-(2,5-二氧代-... 4-((S)-2-((S)-2-(6-(2,5-Diox... |
98% |
|
|
| 毕得 | BD317613-5g | 5g | 现货 |
4-((S)-2-((S)-2-(6-(2,5-二氧代-... 4-((S)-2-((S)-2-(6-(2,5-Diox... |
98% |
|
|
| 韶远 | SY034484-0.25g | 0.25g | 现货 |
MC-Val-Cit-PAB-MMAE MC-Val-Cit-PAB-MMAE |
>97% |
|
|
| 韶远 | SY034484-0.1g | 0.1g | 现货 |
MC-Val-Cit-PAB-MMAE MC-Val-Cit-PAB-MMAE |
>97% |
|
|
| 韶远 | SY034484-1g | 1g | 现货 |
MC-Val-Cit-PAB-MMAE MC-Val-Cit-PAB-MMAE |
>97% |
|
|
| TRC | V415650-100mg | 100mg | 期货,请咨询 | Vedotin | 咨询 | 请联系客服购买! | |
| solarbio | YS157437-100mg | 100mg | 请咨询 | VcMMAE游离态 |
|
|
|
| solarbio | YS157437-10mg | 10mg | 请咨询 | VcMMAE游离态 |
|
|
|
| solarbio | YS157437-50mg | 50mg | 请咨询 | VcMMAE游离态 |
|
|
|
| solarbio | IV0900-1mg | 1mg | 请咨询 | VCMMAE |
|
|
|
| 安耐吉 | E121853-100mg | 100mg | 现货 |
VcMMAE游离态 4-((S)-2-((S)-2-(6-(2,5-diox... |
98+% |
|
|
| 安耐吉 | E121853-1g | 1g | 现货 |
VcMMAE游离态 4-((S)-2-((S)-2-(6-(2,5-diox... |
98+% |
|
|
| 安耐吉 | E121853-250mg | 250mg | 现货 |
VcMMAE游离态 4-((S)-2-((S)-2-(6-(2,5-diox... |
98+% |
|
|
| 安耐吉 | E121853-50mg | 50mg | 现货 |
VcMMAE游离态 4-((S)-2-((S)-2-(6-(2,5-diox... |
98+% |
|
|
| 安耐吉 | M0151778-1mg | 1mg | 现货 |
4-((S)-2-(S)-2-(6-(2,5-二氧-2,... 4-((S)-2-((S)-2-(6-(2,5-diox... |
Reference Standards, 98% |
|
|
| 源叶 | S86084-1mg | 1mg | 现货 |
VcMMAE VcMMAE |
≥99% |
|
|
| 源叶 | S86084-5mg | 5mg | 现货 |
VcMMAE VcMMAE |
≥99% |
|
|
| 源叶 | S86084-10mg | 10mg | 现货 |
VcMMAE VcMMAE |
≥99% |
|
|
| 源叶 | S86084-50mg | 50mg | 现货 |
VcMMAE VcMMAE |
≥99% |
|
|
| 源叶 | S86084-100mg | 100mg | 现货 |
VcMMAE VcMMAE |
≥99% |
|
|
| 源叶 | T29462-1ml | 1ml | 期货,请咨询 |
VcMMAE VcMMAE |
10mM in DMSO |
|
|
| Target Mol | T4232-2mg | 2 mg | 现货 |
化合物VCMMAE VCMMAE |
99.56% |
|
|
| Target Mol | T4232-5mg | 5 mg | 现货 |
化合物VCMMAE VCMMAE |
99.56% |
|
|
| Target Mol | T4232-10mg | 10 mg | 现货 |
化合物VCMMAE VCMMAE |
99.56% |
|
|
| Target Mol | T4232-50mg | 50 mg | 现货 |
化合物VCMMAE VCMMAE |
99.56% |
|
|
| Target Mol | T4232-100mg | 100 mg | 现货 |
化合物VCMMAE VCMMAE |
99.56% |
|
|
| Target Mol | T4232-25mg | 25 mg | 现货 |
化合物VCMMAE VCMMAE |
99.56% |
|
|
| Am | A153774-5mg | 5mg | 现货 |
4-((S)-2-((S)-2-(6-(2,5-二氧代-... 4-((S)-2-((S)-2-(6-(2,5-Diox... |
98 |
|
|
| Am | A153774-1mg | 1mg | 现货 |
4-((S)-2-((S)-2-(6-(2,5-二氧代-... 4-((S)-2-((S)-2-(6-(2,5-Diox... |
98 |
|
|
| Am | A153774-100mg | 100mg | 现货 |
4-((S)-2-((S)-2-(6-(2,5-二氧代-... 4-((S)-2-((S)-2-(6-(2,5-Diox... |
98 |
|
|
| Am | A153774-50mg | 50mg | 现货 |
4-((S)-2-((S)-2-(6-(2,5-二氧代-... 4-((S)-2-((S)-2-(6-(2,5-Diox... |
98 |
|
|
| Am | A153774-10mg | 10mg | 现货 |
4-((S)-2-((S)-2-(6-(2,5-二氧代-... 4-((S)-2-((S)-2-(6-(2,5-Diox... |
98 |
|
|
| Am | A153774-25mg | 25mg | 现货 |
4-((S)-2-((S)-2-(6-(2,5-二氧代-... 4-((S)-2-((S)-2-(6-(2,5-Diox... |
98 |
|
|
| MCE | HY-15575G-100mg | 100mg | 现货 |
VcMMAE (GMP) VcMMAE (GMP) |
|
|
|
| MCE | HY-15575-500mg | 500mg | 现货 |
VcMMAE VcMMAE |
99.97% |
|
|
| MCE | HY-15575G-50mg | 50mg | 现货 |
VcMMAE (GMP) VcMMAE (GMP) |
|
|
|
| MCE | HY-15575-100mg | 100mg | 现货 |
VcMMAE VcMMAE |
99.97% |
|
|
| MCE | HY-15575-50mg | 50mg | 现货 |
VcMMAE VcMMAE |
99.97% |
|
|
| MCE | HY-15575G-10mg | 10mg | 现货 |
VcMMAE (GMP) VcMMAE (GMP) |
|
|
|
| MCE | HY-15575G-5mg | 5mg | 现货 |
VcMMAE (GMP) VcMMAE (GMP) |
|
|
|
| MCE | HY-15575-10mg | 10mg | 现货 |
VcMMAE VcMMAE |
99.97% |
|
|
| MCE | HY-15575-5mg | 5mg | 现货 |
VcMMAE VcMMAE |
99.97% |
|
|